Aditya Birla Sun Life Pharma And Healthcare Fund Direct Growth | Pros & Cons NAV(17.61)

Aditya Birla Sun Life Pharma And Healthcare Fund Direct Growth

Fund Information

Objective

Very High Risk

Nifty Pharma

Benchmark

2019-07-10

Launched On

Type

--

Min SIP

1000

Min Investment

567

AUM in Crores

1.1

Expense Ratio

1.00

Exit Load

Aditya Birla Sun Life AMC Limited

Fund House

Dhaval Shah

Fund Managers

Aditya Birla Sun Life Pharma And Healthcare Fund Direct Pros & Cons

Pros

    Cons

    • Higher Expense Ratio
    • Aditya Birla Sun Life Pharma And Healthcare Fund Direct Growth is ranking 18th in last 5 years

    Average Returns

    Fund Name1Y (%)3Y (%)5Y (%)7Y (%)10Y (%)15Y (%)
    Aditya Birla Sun Life Pharma And Healthcare Fund Direct Growth 
    11.48
    Nifty Pharma
    6.2416.45.162.3411.2811.83

    Aditya Birla Sun Life Pharma And Healthcare Fund Direct Rolling Returns

    Fund Name3 Year (%)5 Year (%)
    AverageMaxMinAverageMaxMin
    Aditya Birla Sun Life Pharma And Healthcare Fund Direct Growth 
    Nifty Pharma
    15.4346.82-14.614.7833.55-12.05

    Risk Parameters

    Fund NameMeanStdSharpeBetaAlpha
    Aditya Birla Sun Life Pharma And Healthcare Fund Direct Growth 
    -----
    Nifty Pharma
    -----
    Risk Parameters are calculated for the last 3 years data.

    Calender Year Returns

    Performance

    Best PerformanceWorst Performance
    PeriodReturnsPeriodReturns
    Week2020-04-03 - 2020-04-10
    16.26
    2020-03-11 - 2020-03-18
    -12.2
    Month2020-03-24 - 2020-04-24
    31.13
    2020-02-19 - 2020-03-19
    -18.3
    Quarter2020-03-23 - 2020-07-23
    42.3
    2019-11-25 - 2020-03-25
    -10.24
    Year2020-03-23 - 2021-03-23
    72.9
    2021-06-11 - 2022-06-11
    -0.15

    Portfolio

    Stock NameSector% of Total Holdings
    Sun Pharmaceutical Industries Ltd.Healthcare11.26
    Dr. Reddy's Laboratories Ltd.Healthcare9.99
    Cipla Ltd.Healthcare8.88
    Divi's Laboratories Ltd.Healthcare8.27
    Aurobindo Pharma Ltd.Healthcare6.31
    Lupin Ltd.Healthcare6.01
    Apollo Hospitals Enterprise Ltd.Healthcare4.89
    Alkem Laboratories Ltd.Healthcare4.12
    Torrent Pharmaceuticals Ltd.Healthcare3.61
    Fortis Healthcare Ltd.Healthcare3.41
    Metropolis Healthcare Ltd.Healthcare3.06
    Atul Ltd.Chemicals2.83
    Zydus Wellness Ltd.FMCG2.55
    Ipca Laboratories Ltd.Healthcare2.44
    Sanofi India Ltd.Healthcare2.43
    Gland Pharma Ltd.Healthcare2.34
    Cadila Healthcare Ltd.Healthcare2.14
    Solara Active Pharma Science Ltd.Healthcare2.08
    Pfizer Ltd.Healthcare1.87
    Abbott India Ltd.Healthcare1.75
    Indoco Remedies Ltd.Healthcare1.74
    Eris Lifesciences Ltd.Healthcare1.62
    Biocon Ltd.Healthcare1.51
    Ajanta Pharma Ltd.Healthcare1.25
    Strides Pharma Science Ltd.Healthcare0.91
    Alembic Pharmaceuticals Ltd.Healthcare0.3
    Sun Pharmaceutical IndustriesHealthcare13.26
    CiplaHealthcare9.43
    Divi's LaboratoriesHealthcare9.23
    Dr. Reddy's LabHealthcare8.98
    Alkem LaboratoriesHealthcare5.82
    Gland PharmaHealthcare4.92
    Torrent PharmaceuticalsHealthcare4.74
    Apollo HospitalsHealthcare4.62
    Aurobindo PharmaHealthcare3.85
    Ipca LaboratoriesHealthcare3.38
    Fortis HealthcareHealthcare2.84
    Sanofi IndiaHealthcare2.71
    Zydus WellnessFMCG2.57
    AtulChemicals2.51
    Metropolis HealthcareHealthcare2.32
    Ajanta PharmaHealthcare2.09
    Abbott IndiaHealthcare2
    BioconHealthcare1.88
    PfizerHealthcare1.82
    Eris LifesciencesHealthcare1.81
    Vijaya Diagnostic CentreHealthcare1.74
    Solara Active Pharma SciencesHealthcare1.69
    Indoco RemediesHealthcare1.59
    LupinHealthcare0.86
    Glenmark Pharma.Healthcare0.83

    AUM Yearly

    Aditya Birla Sun Life Pharma And Healthcare Fund Direct Details

    Aditya Birla Sun Life Pharma And Healthcare Fund Direct Growth is a mutual fund scheme launched by Aditya Birla Sun Life AMC Limited.This fund has been launched on 2019-07-10. Aditya Birla Sun Life Pharma And Healthcare Fund Direct Growth currently has 567 crores of assets under management (AUM) and has an expense ratio of 1.1 which is higher than what most other Large Cap funds charge.


    Aditya Birla Sun Life Pharma And Healthcare Fund Direct Growth has given returns of 11.48% in the last 1 year and % in the last 3 years. And since launch the fund has given 22.22% returns.


    This fund invests in companies which are fundamentally strong and having growth potential.


    The top holdings of the fund are Sun Pharmaceutical Industries Ltd. , Dr. Reddy's Laboratories Ltd. , Cipla Ltd. , Divi's Laboratories Ltd. , Aurobindo Pharma Ltd.

    Frquently Asked Questions

    1. What is the NAV of Aditya Birla Sun Life Pharma And Healthcare Fund Direct ?

    The current Net Asset Value (NAV) of the Aditya Birla Sun Life Pharma And Healthcare Fund Direct is 17.61

    2. Aditya Birla Sun Life Pharma And Healthcare Fund Direct Rolling Returns

    The 3 year rolling returns of the Aditya Birla Sun Life Pharma And Healthcare Fund Direct :

    • Mean : %
    • Max : %
    • Min : %

    3. How do I invest in Aditya Birla Sun Life Pharma And Healthcare Fund Direct ?

    1. Click here Invest Now
    2. Select one Broker platform from the pop up
    3. Invest and enjoy the returns

    Aditya Birla Sun Life Pharma And Healthcare Fund Direct Growth



    Investment Duration 3 years

    Disclaimer

    Please note that these calculators are for illustrations only and do not represent actual returns. Mutual Funds do not have a fixed rate of return and it is not possible to predict the rate of return.